 TA294820 |
- |
Providencia alcalifaciens strain 2019-04-29291-1-1 isolate 2019-04-29291-1-1 (chromosome) |
NZ_OU659204 |
LDO73_RS02340 (higB) |
LDO73_RS02345 (higA) |
higBA (relBE)/COG4683-HTH_37 |
| TA294821 |
- |
Providencia alcalifaciens strain 2019-04-29291-1-1 isolate 2019-04-29291-1-1 (chromosome) |
NZ_OU659204 |
LDO73_RS02405 (PP_4152) |
LDO73_RS02410 (PP_4151) |
PP_4151-4152/excise(antitoxin) |
| TA294822 |
- |
Providencia alcalifaciens strain 2019-04-29291-1-1 isolate 2019-04-29291-1-1 (chromosome) |
NZ_OU659204 |
LDO73_RS03625 (Hha) |
LDO73_RS03630 (TomB) |
Hha-TomB/- |
| TA294823 |
- |
Providencia alcalifaciens strain 2019-04-29291-1-1 isolate 2019-04-29291-1-1 (chromosome) |
NZ_OU659204 |
LDO73_RS06380 (ccdB) |
LDO73_RS06385 (ccdA) |
ccdAB/CcdA(antitoxin) |
| TA294824 |
- |
Providencia alcalifaciens strain 2019-04-29291-1-1 isolate 2019-04-29291-1-1 (chromosome) |
NZ_OU659204 |
LDO73_RS06390 (KacT) |
LDO73_RS06385 (ccdA) |
KacT-ccdA/CcdA(antitoxin) |
| TA294825 |
- |
Providencia alcalifaciens strain 2019-04-29291-1-1 isolate 2019-04-29291-1-1 (chromosome) |
NZ_OU659204 |
LDO73_RS06390 (KacT) |
LDO73_RS06395 (KacA) |
kacAT/DUF1778(antitoxin) |
| TA294826 |
- |
Providencia alcalifaciens strain 2019-04-29291-1-1 isolate 2019-04-29291-1-1 (chromosome) |
NZ_OU659204 |
LDO73_RS11980 (mazF) |
LDO73_RS11975 (mazE) |
mazEF/MazF-MazE |
| TA294828 |
- |
Providencia alcalifaciens strain 2019-04-29291-1-1 isolate 2019-04-29291-1-1 (chromosome) |
NZ_OU659204 |
LDO73_RS16240 (vagD) |
LDO73_RS16245 (vagC) |
vagCD/VapC-VagC |
| TA294829 |
- |
Providencia alcalifaciens strain 2019-04-29291-1-1 isolate 2019-04-29291-1-1 (chromosome) |
NZ_OU659204 |
LDO73_RS17600 (PumA) |
LDO73_RS17595 (relB) |
PumA-relB/upstrm_HI1419-dnstrm_HI1420 |
| TA294830 |
- |
Providencia alcalifaciens strain 2019-04-29291-1-1 isolate 2019-04-29291-1-1 (chromosome) |
NZ_OU659204 |
LDO73_RS17945 (hipA) |
LDO73_RS17950 (hipB) |
hipBA/HipA-HipB |